Key Takeaways
- Revenue optics mask underlying shift: Reported revenue declined due to an accounting policy change and the exit of the plain gold business, but management is deliberately pivoting toward higher ROE, ROCE segments to improve profitability.
- D2C segment is the margin engine: Owned brands D2C revenue grew 30% YoY with EBITDA margins improving 340 bps to 7.6%, driven by e-commerce profitability and a structural shift toward lab grown diamonds.
- Lab grown diamonds now dominate D2C: Lab grown diamonds account for 55% of D2C business, and management expects the penetration trajectory to continue for the next four or five years, carrying slightly higher gross margins than natural diamonds.
- Visibility is the quarter's fragility: Lead times have compressed to ~6 weeks and management has low visibility on the crucial Christmas season, deferring any full-year guidance until the end of Q2.
- What to watch next quarter: Whether Christmas order visibility materializes within the next 30 days as expected, the initial consumer response to lab grown diamonds in Irasva stores, and the Q3 impact of the promised ₹20–25 crore in annualized cost savings.
Strategic Pivot: Quality Over Top Line
- Accounting change masks the story: Prior to FY21, the gold business added ~₹800 crore to the top line on a gross basis; it is now reported net, so the exit of plain gold further depresses reported revenue while improving capital efficiency.
- Plain gold exit closed: The Dubai-based plain gold business was sold effective August 1, 2024, releasing ₹70–80 crore in liquidity to reduce debt and exiting a business management describes as low ROE, ROCE.
- Inventory reset: Exiting plain gold reduced overall inventory by ₹75 crore from its February 2024 peak, though inventory remains elevated now to support a strong order book for FY25.
- Customer brand segment stagnant: The legacy B2B customer brand business has been flat for years and is also characterized as a low ROE, ROCE business, reinforcing the rationale for shifting focus to licensing and D2C.
Sumit Shah: "Some of the revenue growth not showing up is due to a change in accounting policy, and with the exit of the plain gold business, the reported revenue number will be lower. However, we are focusing on high ROE, ROCE businesses which actually enhance the return on capital employed and focusing on better quality businesses which improve profitability."
D2C & Branded Segment: The Margin Story
- Owned brands D2C delivered the quarter's standout performance: Segment revenue rose 30% YoY and EBITDA margin reached 7.6%, a 340 bps improvement, with e-commerce businesses profitable on a first-order basis.
- India retail is the drag: The India brick-and-mortar retail business is not yet profitable and weighs on the branded segment; excluding it, e-commerce businesses are already in the black. India revenue is expected at ₹30–32 crore this year with breakeven targeted in FY26.
- US owned brands growth expected at 20–30% this year, with EBITDA margins targeted in the 15–20% range over a two-to-three-year horizon.
- Consolidated website coming: A single website called Wonder Fine Jewellery, housing all licensed brands under a company-owned banner, is planned for launch in November 2024 (Q3), which could improve marketing efficiency.
- RFMI global expansion: The brand is set to launch in the UK and India in upcoming quarters; the website is ready but marketing spend has not yet begun.
- Licensed brand strategy narrowing: Management is concentrating on what works (Disney Princesses, Disney Treasures, Hallmark, Star Wars) rather than expanding the brand universe, after only moderate success with Barbie and Warner Brothers/DC collections.
Sumit Shah: "I think our strategy in order to improve margins is to really focus on the brands that are working and not expand the universe of brands too much."
Lab Grown Diamonds: The Structural Shift
- Penetration is deep and growing: Lab grown diamonds now represent 55% of D2C business, and B2B contribution increased 50% YoY as key partners worldwide adopt the category.
- Margin profile is favorable but carries inventory risk: Lab grown diamond gross margins are slightly higher than natural, but prices have been declining, so increased penetration should lift margins over time while requiring careful inventory management.
- Brand-first, not manufacturing-first: The company is strategically focused on building lab grown diamond brands rather than entering manufacturing, positioning for the demand side of the transition.
- India retail launch underway: Lab grown diamonds began selling through four Irasva stores less than 30 days before the call; management expects to share feedback in coming quarters.
- Transition is secular, not quarterly: Management sees the shift as a slow, multi-year trajectory lasting four to five years, not something that plays out in one or two quarters.
Sumit Shah: "The changeover to lab grown diamonds is not going to happen in one or two quarters. But slowly but surely we are seeing an increased penetration of lab grown diamonds with all of our key partners worldwide."
Demand Environment & Visibility
- US macro is subdued: Discretionary spending is under pressure from sustained high inflation, and Q1 was subdued at the company level, though the factory order book for July, August and partially into September has been relatively strong.
- Lead times have compressed: Customers are placing orders closer to delivery, with lead times now ~6 weeks versus 8–10 weeks previously, reflecting uncertainty and reducing forward visibility.
- Christmas visibility is the critical unknown: Customers are in the process of finalizing holiday orders; management expects much clearer visibility within 30 days and says end of Q2 is the right moment to provide full-year guidance.
- European demand not addressed: When asked specifically about European market trends, management did not provide detail, focusing commentary on the US.
Sumit Shah: "I think that we have low visibility on the season so far, we should be able to give much better guidance the following quarter, as the Christmas season is a crucial part of our profitability for the year. So, end of Q2 would be a good time for us to give visibility on the year."
Margin & Cost Roadmap
- Cost structure acknowledged as elevated: Management stated that for a ₹1,600–1,700 crore diamond jewellery business, margins should be in double digits, and the combination of the lab grown diamond shift plus cost efficiency is the path to get there.
- Cost control program quantified: Annualized savings of ₹20–25 crore are expected starting Q3 of this financial year, contributing to the double-digit growth endeavor whether or not revenue growth delivers.
- D2C margin target set: Management plans to enhance D2C EBITDA margins to 15–20% over the next few years, up from the current 7.6%.
- India retail breakeven in FY26: The India business, currently a drag, is expected to reach breakeven and turn profitable next fiscal year on revenue of ₹30–32 crore in the current year.
Sumit Shah: "I think that structural shift more towards lab grown diamonds and becoming more efficient on a cost side, for us as a Company, a combination of the two things should help us grow margins, not just the shift towards lab grown diamonds."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Cost savings realization | ₹20–25 crore annualized savings | Starting Q3 FY25 |
| Consolidated website launch | Wonder Fine Jewellery site housing all licensed brands | November 2024 (Q3 FY25) |
| India business breakeven | India retail turns profitable | FY26 |
| India business revenue | ₹30–32 crore | Current year (FY25) |
| US owned brands growth | 20–30% growth | Current year (FY25) |
| US owned brands EBITDA margin | 15–20% range | Two-to-three-year time frame |
| D2C segment EBITDA margin | 15–20% | Over the next few years |
| Christmas order visibility | Materially clearer order book | Within 30 days of call |
| Full-year guidance | Management will provide visibility on the year | End of Q2 FY25 |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Total income | ₹447 cr, down 6% YoY from ₹476 cr |
| EBITDA | ₹39 cr, up 6.1% YoY from ₹37 cr |
| EBITDA margin | 8.8%, up from 7.7% YoY, a 100 bps improvement |
| Profit after tax | ₹15.4 cr, up from ₹14.2 cr YoY |
| Owned brands D2C revenue | ₹50 cr, up 30% YoY |
| Owned brands D2C EBITDA margin | 7.6%, improved 344 bps YoY |
| Licensed brand revenue | ₹86 cr, EBITDA margin of 16.2% |
| US owned brands revenue | ₹46 cr |
| Irasva (India D2C) revenue | ₹4 cr, across 4 stores |
| Studded jewellery share of revenue | 84% |
| Branded jewellery share of studded revenue | 37% |
| Lab grown diamond share of D2C business | 55% |
| Lab grown diamond share of studded jewellery | 15% |
| Net debt-to-equity ratio | 0.31, versus 0.28 in March 2024 and 0.22 in June 2023 |
| Total net debt | ₹370 cr, versus ₹233 cr in Q1 FY24 |
| Cash and bank balance and current investments | ₹186 cr |
| US share of overall sales | 65% to 70%, expected to rise to ~75% after Dubai gold business exit |
| Annualized cost savings expected from Q3 FY25 | ₹20 cr to ₹25 cr |
| Plain gold business quarterly EBITDA impact upon exit | ₹2 cr to ₹3 cr reduction, with minimal bottom-line impact |